Factors Affecting the Time to Start Postoperative Chemotherapy in Colorectal Cancer

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

800 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-20

Study Completion Date

2021-04-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Colorectal cancers are common tumors and have undergone a great change in the last 20 years in terms of treatment principles. Significantly improved results in local recurrence and overall survival have begun to be obtained with chemotherapy protocols given after surgery, which is the main element of the treatment system (1). It is known that postoperative chemotherapy protocols are commonly given within 6-8 weeks and this period is optimal. However, it was found that this period was prolonged in approximately 20% of these patients in the methanalysis performed (2). It has been shown that delay in applied chemotherapy causes a decrease in overall survival (3,4). The factors causing this delay have not been adequately examined in the literature. It is necessary to investigate these factors that affect the overall survival outcomes, which are the main pillars of treatment principles, and to regulate the factors that have the opportunity to improve.

In this study, our aim is to investigate the perioperative (preop-perop-postop) factors affecting the duration of postoperative chemotherapy initiation in patients with colorectal cancer treated in our hospital.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluating Factors Affecting Survival in Colon and Rectum Cancer

NCT05388513

Colon Cancer Rectum Cancer

COMPLETED

Appropriate Timing of Surgery After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

NCT03287843

Neoplasm, Rectum

COMPLETED NA

Can Neoadjuvant Chemoradiotherapy be Ommited in Mid-rectal Cancer

NCT06823297

Mid-Rectal Cancer Rectal Cancer Stage II Rectal Cancer Stage III

NOT_YET_RECRUITING

Intra-operative Chemotherapy With 5-FU for Colorectal Cancer Patients Receiving Curative Resection: Efficacy and Safety

NCT01465451

Colorectal Cancer

UNKNOWN PHASE3

Real-world Retrospective Data Analysis of Adjuvant Therapy for Patients With Stage II-III Colon Cancer After Radical Surgery

NCT03958435

Stage II Colon Cancer Stage III Colon Cancer Adjuvant Therapy

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

the Time to Start Postoperative Chemotherapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

patients who underwent colorectal resection

Exclusion Criteria

patients with missing data

Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ersin Gündoğan

Assoc Prof

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

ersin Gundogan, Assoc Prof

Role: STUDY_DIRECTOR

Health Science University- Kayseri State Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Health science University - Kayseri State Hospital

Kocasinan, Kayseri, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021/368

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Investigation of the Effect of Training on the Side Effects of Chemotherapy Given Via the Mobile Health Application on the Quality of Life in Colorectal Cancer Patients

NCT05940740 COMPLETED NA

Oncologic Risk of Rectal Preservation Against Medical Advice After Chemoradiotherapy for Rectal Cancer

NCT03923309 COMPLETED

Rectal Preserving Treatment for Early Rectal Cancer. A Multi-centred Randomised Trial of Radical Surgery Versus Adjuvant Chemoradiotherapy After Local Excision for Early Rectal Cancers

NCT02371304 UNKNOWN PHASE3

Neoadjuvant Triplet Chemotherapy Regimen in Patients With Resectable Colorectal Cancer

NCT02688023 UNKNOWN PHASE2

The Effect of Minimally Invasive Surgery on Systemic Inflammatory Response in Rectal Cancer

NCT06540027 ENROLLING_BY_INVITATION

Organ-preserving Management in Patients With Complete or Near-complete Tumour Response After Preoperative Radio(Chemo)Therapy for Rectal Cancer

NCT04095468 RECRUITING

Quality of Life and Psychosocial Status of Young-onset Patients With Rectal Cancer

NCT06216834 RECRUITING

Timing for Rectal Surgery After Chemoradiotherapy

NCT03607370 ACTIVE_NOT_RECRUITING NA

Outcomes of Resection at Different Times Between the End of Neoadjuvant Treatment and Surgery

NCT04013347 COMPLETED

The Role of Vitamin D in Predicting Response to Neoadjuvant Therapy in Patients With Rectal Cancer

NCT04857203 UNKNOWN

Observational Study on the Patients With Rectal Cancer

NCT02312284 COMPLETED

Additional Chemotherapy After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer

NCT01671683 COMPLETED

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

NCT06758830 RECRUITING PHASE2/PHASE3

The dıagnostıc Value of Serum autotaxın Level ın Colorectal Cancer

NCT06091592 COMPLETED

Early Commencement of Adjuvant Chemotherapy for Colon Cancer

NCT01460589 UNKNOWN PHASE3

Delayed Systemic Therapy Following Destructive Local Treatment of Pulmonary Oligometastases After No Evidence of Disease (NED) in Colorectal Cancer.

NCT06778382 RECRUITING PHASE2

Studying Biomarkers in Tumor Tissue and Blood Samples From Patients Undergoing Chemotherapy and Radiation Therapy for Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery

NCT00960427 WITHDRAWN PHASE1

Study of Postoperative Concurrent Chemo-radiation With Capecitabine in Elderly Rectal Cancer Patients

NCT01268943 COMPLETED PHASE1

Chemotherapy With DNA Damaging Agents In Colorectal Cancer

NCT01456923 COMPLETED PHASE1

Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks

NCT01037049 UNKNOWN PHASE2

Chemoradiotherapy After Surgery Versus Preoperative Chemoradiotherapy for Stage II/III Mid-low Rectal Cancer With or Without High-risk Factors

NCT06566222 NOT_YET_RECRUITING

Short-course Preoperative Chemoradiotherapy Followed by Delayed Operation for Locally Advanced Rectal Cancer

NCT01129700 COMPLETED PHASE2

Prognostic Factors Affecting Recurrence and Disease-Free Survival After Surgical Resection for Cancer Rectum

NCT06096493 UNKNOWN

Survival Benefit of Primary Tumour Resection Compared to Systemic Therapy Alone in Stage IV Colorectal Cancer Patients

NCT06326619 COMPLETED

Improving 5-Fluorouracil (5-FU) Continuous Infusion Comfort With a New Corset Design in People Affected by Cancer

NCT07317583 COMPLETED NA